Michael Higgins

ROTH Capital Partners

Image: Michael Higgins

Michael Higgins is a senior life sciences analyst at Highline Research Advisors LLC. Prior to that he was Brinson Patrick Securities' first analyst and established the research platform. Prior to joining Brinson Patrick, Higgins was a managing director and senior specialty pharmaceuticals analyst at Rodman & Renshaw. Prior to joining Rodman & Renshaw, Higgins gained 10 years of drug marketing experience with Procter & Gamble Pharmaceuticals, followed by 12 years as a research analyst. He has worked as an analyst with Dafna Capital Management, Wedbush Securities and an independent research firm he founded, 4sight Research Partners. Higgins has earned a four-star rating from StarMine for stock recommendation performance. He is most recognized for his coverage of "drug launch" companies, as well as drug delivery technologies and patents. Higgins received his bachelor's degree in finance from the University of Wisconsin and his master's of business administration from Marquette University.



Due to permission requirements, not all quotes are shown.